Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
114.5 EUR | -1.04% | +5.72% | -12.99% |
May. 28 | REDCARE PHARMACY : Buy rating from Jefferies | ZD |
May. 24 | REDCARE PHARMACY : Deutsche Bank keeps its Buy rating | ZD |
Sales 2024 * | 2.38B 2.58B | Sales 2025 * | 2.91B 3.16B | Capitalization | 2.33B 2.53B |
---|---|---|---|---|---|
Net income 2024 * | -7M -7.59M | Net income 2025 * | 41M 44.46M | EV / Sales 2024 * | 1.05 x |
Net Debt 2024 * | 162M 176M | Net Debt 2025 * | 143M 155M | EV / Sales 2025 * | 0.85 x |
P/E ratio 2024 * |
-312
x | P/E ratio 2025 * |
63.4
x | Employees | 1,900 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.87% |
Latest transcript on Redcare Pharmacy NV
1 day | -1.04% | ||
1 week | +5.72% | ||
1 month | -9.84% | ||
3 months | -11.92% | ||
6 months | -9.31% | ||
Current year | -12.99% |
Managers | Title | Age | Since |
---|---|---|---|
Olaf Heinrich
CEO | Chief Executive Officer | 54 | 23-07-31 |
Jasper Eenhorst
DFI | Director of Finance/CFO | 51 | 20-01-31 |
Theresa Holler
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Björn H. Söder
CHM | Chairman | 52 | 15-12-31 |
Frank Köhler
FOU | Founder | 60 | 00-12-31 |
Director/Board Member | 53 | 22-04-13 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.46% | 17 M€ | -.--% | - | |
0.02% | 746 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 114.5 | -1.04% | 117,620 |
24-05-30 | 115.7 | +2.39% | 65,062 |
24-05-29 | 113 | -3.17% | 133,883 |
24-05-28 | 116.7 | +5.32% | 180,071 |
24-05-27 | 110.8 | +2.31% | 92,056 |
Delayed Quote Xetra, May 31, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.99% | 2.53B | |
-37.88% | 13.99B | |
-33.12% | 10.67B | |
+12.54% | 6.29B | |
-11.17% | 5.88B | |
+75.00% | 4.96B | |
-4.38% | 4.54B | |
-9.20% | 3.74B | |
-19.40% | 3.16B | |
-12.15% | 2.85B |
- Stock Market
- Equities
- RDC Stock